Abraham Ajayi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Abraham Ajayi has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Stella Ifeanyi Smith
Molecular Biology and Biotechnology Department Nigerian Institute of Medical Research Lagos Nigeria
14 shared publications - Utibeima Udo Essiet
Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria
7 shared publications Adeyemi Isaac Adeleye
Department of Microbiology, University of Lagos, Akoka , Nigeria
4 shared publications- Tenny Obiageli Gladys Egwuatu
Department of Microbiology, Faculty of Science, University of Lagos, Akoka, Nigeria
3 shared publications - Abiodun Tola Seriki
Department of Biological Sciences, College of Natural and Applied Sciences, Bells University of Technology, Ota, Ogun State, Nigeria
2 shared publications Afolabi Lesi
Department of Paediatrics, College of Medicine, University of Lagos Idi-Araba, Lagos Nigeria
2 shared publications
Latest Publications
- Open Access
- 8 August 2026
- Published by Springer Nature in BMC Genomic Data
- Vol. 27 (1)
Genomic analysis of ESBL-producing Klebsiella pneumoniae strain AA isolated from irrigated vegetables in Lagos, Nigeria
- 8 August 2026
- Published by Springer Nature in BMC Genomic Data
- Vol. 27 (1)
Open AccessGenomic analysis of ESBL-producing Klebsiella pneumoniae strain AA isolated from irrigated vegetables in Lagos, Nigeria
- 17 April 2026
- Published by Elsevier in Microbial Pathogenesis
- Vol. 216, 108493
Genetic diversity of ESBL-producing Enterobacteriaceae isolated from pit latrines in urban and suburban communities in Lagos, Nigeria
- 17 April 2026
- Published by Elsevier in Microbial Pathogenesis
- Vol. 216, 108493
Genetic diversity of ESBL-producing Enterobacteriaceae isolated from pit latrines in urban and suburban communities in Lagos, Nigeria
- Open Access
- 28 March 2025
- Published by Springer Nature in Discover Geoscience
- Vol. 3 (1) , 1-17
Assessment of awareness and levels of preparedness for humanitarian disasters across some geopolitical zones in Nigeria
- 28 March 2025
- Published by Springer Nature in Discover Geoscience
- Vol. 3 (1) , 1-17
Open AccessAssessment of awareness and levels of preparedness for humanitarian disasters across some geopolitical zones in Nigeria
- Open Access
- 1 January 2025
- Published by XMLink in Infection & Chemotherapy
- Vol. 57 (4) , 627-628
Reply: Genomic Insights and Antimicrobial Resistance: Addressing the Burden of Neonatal Sepsis in Africa
Seriki AT, et al. Infect Chemother. 2025 Nov;57:e63. https://doi.org/10.3947/ic.2025.0119
- 1 January 2025
- Published by XMLink in Infection & Chemotherapy
- Vol. 57 (4) , 627-628
Open AccessReply: Genomic Insights and Antimicrobial Resistance: Addressing the Burden of Neonatal Sepsis in Africa
Seriki AT, et al. Infect Chemother. 2025 Nov;57:e63. https://doi.org/10.3947/ic.2025.0119
- Open Access
- 1 January 2025
- Published by XMLink in Infection & Chemotherapy
- Vol. 57 (2) , 316-320
Genomic Analysis of Multidrug Resistant Enterobacter hormaechei Strain AH1-NIMR Isolated from a Neonate with Sepsis in Lagos, Nigeria
Seriki AT, et al. Infect Chemother. 2025 Jun;57:e40. https://doi.org/10.3947/ic.2025.0040
- 1 January 2025
- Published by XMLink in Infection & Chemotherapy
- Vol. 57 (2) , 316-320
Open AccessGenomic Analysis of Multidrug Resistant Enterobacter hormaechei Strain AH1-NIMR Isolated from a Neonate with Sepsis in Lagos, Nigeria
Seriki AT, et al. Infect Chemother. 2025 Jun;57:e40. https://doi.org/10.3947/ic.2025.0040
- Open Access
- 1 January 2025
- Published by XMLink in Infection & Chemotherapy
- Vol. 57 (1) , 102-110
Genetic Determinants of Carbapenem and Fluoroquinolone Resistance in Escherichia coli Isolates of Clinical Origin
Lawal ST, et al. Infect Chemother. 2025 Mar;57:e15. https://doi.org/10.3947/ic.2024.0108
- 1 January 2025
- Published by XMLink in Infection & Chemotherapy
- Vol. 57 (1) , 102-110
Open AccessGenetic Determinants of Carbapenem and Fluoroquinolone Resistance in Escherichia coli Isolates of Clinical Origin
Lawal ST, et al. Infect Chemother. 2025 Mar;57:e15. https://doi.org/10.3947/ic.2024.0108
- 13 November 2024
- Published by Wiley in Helicobacter
- Vol. 29 (6) , e13153
Helicobacter pylori Management in Africa: A Survey of Diagnostic, Treatment, and Related Resources
Background: Although Helicobacter pylori infection (H. pylori) prevalence in Africa has declined in the last decade, it remains concerningly high. H. pylori is asymptomatic in the majority of patients but is associated with significant morbidity and mortality in 10%–20%.Materials and Methods: We conducted an online survey of 21 African countries, with the link distributed to members of the African Helicobacter Microbiota Study Group. The survey was completed by 562 respondents; the majority were from Nigeria (27.2%), South Africa (18.1%), Tanzania (17.6%), Egypt (16.9%), and Cameroon (14.2%).Results: The most common reason for H. pylori testing was dyspepsia in 83.9% of the cases. Abnormal findings at gastroscopy (62.3%) and heartburn (61.7%) were also common indications. Stool antigen testing and histological examination of gastric biopsies using Giemsa were the two most used methods for H. pylori testing at 62.3% and 50.3%, respectively. Most respondents reported the use of standard clarithromycin‐based triple therapy as first‐line treatment for H. pylori infection.Conclusion: This survey has demonstrated the diversity of practice and resource availability within the African continent. Several international guidelines exist on the management of H. pylori, but little data is available in Africa on how this condition is managed in every day clinical practice. There is an urgent need to formulate evidence‐based and locally relevant practice guidelines on the African continent. In this context, the African Helicobacter and Microbiota study group was formed to coordinate efforts across the continent on H. pylori research to provide guidance on its management. This paper, therefore, aimed to evaluate the practice of H. pylori diagnostics and management, as well as related resources in representative countries in Africa, to facilitate the development of such guidelines.
- 13 November 2024
- Published by Wiley in Helicobacter
- Vol. 29 (6) , e13153
Helicobacter pylori Management in Africa: A Survey of Diagnostic, Treatment, and Related Resources
Background: Although Helicobacter pylori infection (H. pylori) prevalence in Africa has declined in the last decade, it remains concerningly high. H. pylori is asymptomatic in the majority of patients but is associated with significant morbidity and mortality in 10%–20%.Materials and Methods: We conducted an online survey of 21 African countries, with the link distributed to members of the African Helicobacter Microbiota Study Group. The survey was completed by 562 respondents; the majority were from Nigeria (27.2%), South Africa (18.1%), Tanzania (17.6%), Egypt (16.9%), and Cameroon (14.2%).Results: The most common reason for H. pylori testing was dyspepsia in 83.9% of the cases. Abnormal findings at gastroscopy (62.3%) and heartburn (61.7%) were also common indications. Stool antigen testing and histological examination of gastric biopsies using Giemsa were the two most used methods for H. pylori testing at 62.3% and 50.3%, respectively. Most respondents reported the use of standard clarithromycin‐based triple therapy as first‐line treatment for H. pylori infection.Conclusion: This survey has demonstrated the diversity of practice and resource availability within the African continent. Several international guidelines exist on the management of H. pylori, but little data is available in Africa on how this condition is managed in every day clinical practice. There is an urgent need to formulate evidence‐based and locally relevant practice guidelines on the African continent. In this context, the African Helicobacter and Microbiota study group was formed to coordinate efforts across the continent on H. pylori research to provide guidance on its management. This paper, therefore, aimed to evaluate the practice of H. pylori diagnostics and management, as well as related resources in representative countries in Africa, to facilitate the development of such guidelines.
- 27 October 2024
- Published by Egyptian Knowledge Bank in Microbes and Infectious Diseases
Molecular characterization and antimicrobial resistance of bacterial pathogens in neonatal sepsis: A cross-sectional study at a Lagos tertiary hospital
Background: Neonatal sepsis, a high-risk disease, is a major contributory factor to infant morbidity and mortality in low- and middle-income countries. The aim of this study was to isolate and molecularly characterize bacterial pathogens causing sepsis in neonates. Methods: This study characterized and evaluated the antimicrobial susceptibility profile of the bacterial aetiology of neonatal sepsis in the neonatal ward of a tertiary hospital in Lagos. Ninety-five blood samples were collected from neonates presenting with sepsis. Microbiology and molecular biology methods were used for the identification and characterization of bacterial isolates, while antibiotic susceptibility testing was conducted using the Kirby-Bauer disc diffusion method. Results: Of the participants, 67.4% were between 1 day and 1 week old, and 86.3% had an onset of temperature between 1 day and 5 days. Twenty percent of the blood samples were culture positive, revealing 32% Gram-positive bacteria and 60% Gram-negative bacteria. There was no significant difference (p = 0.8374) in the rate of positive blood cultures between male and female participants. The dominant bacterial species identified were Enterobacter quasihormaechei and Enterobacter cancerogenus. Other isolated species included Bacillus aerius, Bacillus inaquosorum, Bacillus paramycoides, Klebsiella pneumoniae, Klebsiella variicola, Staphylococcus hominis, Staphylococcus saccharolyticus, and Cedecea colo. Notably, 95% of the isolates were resistant to cefuroxime, 89% to cefepime, and 74% to amoxicillin + clavulanic acid. Two isolates, AH-1 (Enterobacter roggenkampii) and ON-2 (Cedecea colo), were resistant to eight of the nine tested antibiotics. Conclusion: The high rate of multidrug-resistant bacterial strains implicated in neonatal sepsis underscores the need for routine surveillance and improved hygiene practices in neonatal wards.
- 27 October 2024
- Published by Egyptian Knowledge Bank in Microbes and Infectious Diseases
Molecular characterization and antimicrobial resistance of bacterial pathogens in neonatal sepsis: A cross-sectional study at a Lagos tertiary hospital
Background: Neonatal sepsis, a high-risk disease, is a major contributory factor to infant morbidity and mortality in low- and middle-income countries. The aim of this study was to isolate and molecularly characterize bacterial pathogens causing sepsis in neonates. Methods: This study characterized and evaluated the antimicrobial susceptibility profile of the bacterial aetiology of neonatal sepsis in the neonatal ward of a tertiary hospital in Lagos. Ninety-five blood samples were collected from neonates presenting with sepsis. Microbiology and molecular biology methods were used for the identification and characterization of bacterial isolates, while antibiotic susceptibility testing was conducted using the Kirby-Bauer disc diffusion method. Results: Of the participants, 67.4% were between 1 day and 1 week old, and 86.3% had an onset of temperature between 1 day and 5 days. Twenty percent of the blood samples were culture positive, revealing 32% Gram-positive bacteria and 60% Gram-negative bacteria. There was no significant difference (p = 0.8374) in the rate of positive blood cultures between male and female participants. The dominant bacterial species identified were Enterobacter quasihormaechei and Enterobacter cancerogenus. Other isolated species included Bacillus aerius, Bacillus inaquosorum, Bacillus paramycoides, Klebsiella pneumoniae, Klebsiella variicola, Staphylococcus hominis, Staphylococcus saccharolyticus, and Cedecea colo. Notably, 95% of the isolates were resistant to cefuroxime, 89% to cefepime, and 74% to amoxicillin + clavulanic acid. Two isolates, AH-1 (Enterobacter roggenkampii) and ON-2 (Cedecea colo), were resistant to eight of the nine tested antibiotics. Conclusion: The high rate of multidrug-resistant bacterial strains implicated in neonatal sepsis underscores the need for routine surveillance and improved hygiene practices in neonatal wards.
- 13 May 2024
- Published by Springer Nature in Biologia
- Vol. 79 (7) , 2189-2202
Molecular diversity and antimicrobial susceptibility profile of Vibrio species and distribution of other bacteria isolated from water Hyacinth (Eichornia crassipes) and Lagos lagoon
- 13 May 2024
- Published by Springer Nature in Biologia
- Vol. 79 (7) , 2189-2202
Molecular diversity and antimicrobial susceptibility profile of Vibrio species and distribution of other bacteria isolated from water Hyacinth (Eichornia crassipes) and Lagos lagoon
- Open Access
- 30 March 2024
- Published by Maad Rayan Publishing Company in Avicenna Journal of Clinical Microbiology and Infection
- Vol. 11 (1) , 1-8
Alterations in the Gut Microbiota Composition and Structure of Children Under 5 Years With Sepsis: A Case Report From a Federal Medical Center in Lagos State, Nigeria
Background: Sepsis is a major cause of death among children in Sub-Saharan Africa. Although studies have suggested that the dysbiosis of the gut microbiota is associated with sepsis, there are limited data on the microbiota profile of children with sepsis in low- and middle-income countries such as Nigeria. Methods: To address this gap, this study was conducted to examine the gut microbiota of four children (S2, S4, S6, and S8) with sepsis and two apparently healthy controls (C2 and C4). DNA was extracted from stool samples, and 16S rRNA amplicon sequencing and bioinformatics analysis were used to determine the microbial composition of the microbiota. Results: A significant reduction in the abundance of the phylum Bacteroidetes was observed in sepsis cases, while the family Enterobacteriaceae was dominant, with a relative abundance of 29.7%, 36.9%, 47.4%, and 34.6% in S2, S4, S6, and S8, respectively. Pathogenic bacterial species such as Megasphaera spp., Sutterella spp., and Clostridium difficile were dominant among some of the sepsis samples. The bacterial communities of the microbiota of participants with sepsis largely diverged from those of the controls, with a remarkable decrease in diversity. Conclusion: This study highlights an alteration in the gut microbiota of children presenting with sepsis. Notably, there was a reduction in beneficial commensals and an increase in potential pathogenic bacterial species. Since sepsis remains a major public health challenge, there is an urgent need to explore the gut microbiota for possible intervention.
- 30 March 2024
- Published by Maad Rayan Publishing Company in Avicenna Journal of Clinical Microbiology and Infection
- Vol. 11 (1) , 1-8
Open AccessAlterations in the Gut Microbiota Composition and Structure of Children Under 5 Years With Sepsis: A Case Report From a Federal Medical Center in Lagos State, Nigeria
Background: Sepsis is a major cause of death among children in Sub-Saharan Africa. Although studies have suggested that the dysbiosis of the gut microbiota is associated with sepsis, there are limited data on the microbiota profile of children with sepsis in low- and middle-income countries such as Nigeria. Methods: To address this gap, this study was conducted to examine the gut microbiota of four children (S2, S4, S6, and S8) with sepsis and two apparently healthy controls (C2 and C4). DNA was extracted from stool samples, and 16S rRNA amplicon sequencing and bioinformatics analysis were used to determine the microbial composition of the microbiota. Results: A significant reduction in the abundance of the phylum Bacteroidetes was observed in sepsis cases, while the family Enterobacteriaceae was dominant, with a relative abundance of 29.7%, 36.9%, 47.4%, and 34.6% in S2, S4, S6, and S8, respectively. Pathogenic bacterial species such as Megasphaera spp., Sutterella spp., and Clostridium difficile were dominant among some of the sepsis samples. The bacterial communities of the microbiota of participants with sepsis largely diverged from those of the controls, with a remarkable decrease in diversity. Conclusion: This study highlights an alteration in the gut microbiota of children presenting with sepsis. Notably, there was a reduction in beneficial commensals and an increase in potential pathogenic bacterial species. Since sepsis remains a major public health challenge, there is an urgent need to explore the gut microbiota for possible intervention.